News - Page 202 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Psyched Wellness Provides Update on Pre-Clinical Trial of Its Muscimol Extract AME-1

Psyched Wellness Provides Update on Pre-Clinical Trial of Its Muscimol Extract AME-1

Post published:March 2, 2021
Post category:Press Release

Read more about the article MINDCURE Completes Its Initial Strategic Equity Investment in ATMA, Canada’s First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin

MINDCURE Completes Its Initial Strategic Equity Investment in ATMA, Canada’s First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin

Post published:March 2, 2021
Post category:Press Release

Read more about the article Psychedelics Company Silo Wellness Inc. (Formerly Yukoterre Resources Inc.) Announces Successful Completion of Reverse Take-Over Transaction

Psychedelics Company Silo Wellness Inc. (Formerly Yukoterre Resources Inc.) Announces Successful Completion of Reverse Take-Over Transaction

Post published:March 1, 2021
Post category:Press Release

Read more about the article Novamind Reports Company Highlights and Strong Revenue Growth in Fiscal Second Quarter

Novamind Reports Company Highlights and Strong Revenue Growth in Fiscal Second Quarter

Post published:March 1, 2021
Post category:Press Release

Read more about the article Algernon Pharmaceuticals to Conduct Phase 1 DMT Stroke Program Study with Hammersmith Medicines Research (UK)

Algernon Pharmaceuticals to Conduct Phase 1 DMT Stroke Program Study with Hammersmith Medicines Research (UK)

Post published:March 1, 2021
Post category:Press Release

Read more about the article Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain

Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain

Post published:March 1, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: Field Trip Raising $83m; NYU Langone Launches Psychedelic Medicine Center; the Many Applications of DMT

Psychedelic Bulletin: Field Trip Raising $83m; NYU Langone Launches Psychedelic Medicine Center; the Many Applications of DMT

Post published:February 26, 2021
Post category:Psychedelic Bulletin

Read more about the article MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company

MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company

Post published:February 26, 2021
Post category:Press Release

Read more about the article Field Trip Health Announces Upsize to Previously Announced Bought Deal Public Offering

Field Trip Health Announces Upsize to Previously Announced Bought Deal Public Offering

Post published:February 26, 2021
Post category:Press Release

Read more about the article Field Trip Health Announces $50 Million Bought Deal Offering of Common Shares

Field Trip Health Announces $50 Million Bought Deal Offering of Common Shares

Post published:February 25, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.